Adaptimmune Therapeutics PLC (ADAPY) vs Quantum Biopharma Ltd. (QNTM)

Adaptimmune Therapeutics PLC and Quantum Biopharma Ltd. are both Biotechnology companies. Adaptimmune Therapeutics PLC and Quantum Biopharma Ltd. are of similar size ($14.6M and $14.4M). Quantum Biopharma Ltd. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Adaptimmune Therapeutics PLC leads on 7 and Quantum Biopharma Ltd. on 7.

Valuation

Metric ADAPY QNTM Biotechnology median
P/E n/m n/m 11.36
P/S 0.12 46.20 9.12
P/B n/m 1.76 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 0.12 4.15 8.56
Earnings yield (2,166.67%) (340.99%) (34.18%)
Free cash flow yield (2,432.09%) (84.59%) (23.62%)

Profitability

Metric ADAPY QNTM Biotechnology median
Gross margin 94.81% 0.00% 67.24%
Operating margin (427.75%) 0.00% 0.00%
Net margin (262.46%) 0.00% 0.00%
Free cash flow margin (294.49%) 0.00% 0.00%
Return on equity (1,349.52%) (618.06%) (50.28%)
Return on assets 0.00% (169.48%) (45.89%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAPY QNTM Biotechnology median
Revenue growth (TTM) (53.99%) — 6.96%
EPS growth (last fiscal year) 142.86% 37.50% 29.86%
Revenue growth, 5-year CAGR 8.40% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAPY QNTM Biotechnology median
Debt to equity (0.36) 0.00 0.00
Current ratio 1.52 1.20 4.72
Net debt to EBITDA 0.47 0.31 1.01

Dividend

Metric ADAPY QNTM Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ADAPY QNTM Biotechnology median
Market cap 14.55m 14.40m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack